Health Highlights, April 7, 2022

Is the CDC in crisis? Former agency heads debate its future. A handful of former directors say they support a sweeping review of the agency that's been ordered up by current director Dr. Rochelle Walensky. Read more
Experimental pill may fight antibiotic-resistant UTIs. The new pill, called tebipenem HBr, worked as well as a standard IV antibiotic in treating patients hospitalized with "complicated" UTIs, a study has found. Read more
Upped risk for clots lasts at least 6 months after COVID. A new study suggests that COVID-19 is an independent risk factor for deep vein thrombosis, pulmonary embolism and bleeding, researchers say. Read more
U.S. nursing home industry needs an overhaul. A major new report finds facilities awash in ineffective care and staffing shortages. Its authors call for sweeping changes in an industry whose failures have only been exacerbated by the pandemic. Read more
Are retooled COVID booster shots coming this fall? Federal health officials told an expert advisory panel on Wednesday that clinical trials of potential candidates would have to begin by next month, and a final formula chosen by June. Read more
Related Posts
Two More Brands of Eye Drops Recalled Over Infection Risks
TUESDAY, March 7, 2023 (HealthDay News) -- U.S. federal health officials have...
Los adolescentes que usan marihuana, cigarrillos electrónicos y cigarrillos se enfrentan a un triple peligro
MARTES, 28 de septiembre de 2021 (HealthDay News) -- Más adolescentes de EE. UU....
16 Illnesses, One Death Reported From Listeria in Deli Meat, Cheese
THURSDAY, Nov. 10, 2022 (HealthDay News) -- Public health officials are...
For Dogs, Gastro & Respiratory Ills Often Connected, Study Suggests
TUESDAY, Aug. 29, 2023 (HealthDay News) -- Does your dog struggle to breathe,...
